Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation

References

• Porter DL, Alyea EP, Antin JH, et al. NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on treatment of relapse after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2010;16:1467–1503.
   PubMed Web of Science ®Google Scholar
• Kurosawa S, Yamaguchi T, Miyawaki S, et al. Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse. Haematologica. 2010;95:1857–1864.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Yamamoto W, Ogusa E, et al. Prognostic index for relapsed acute leukemia after allogeneic stem cell transplant. Leuk Lymphoma. 2014;55:2808–2812.
   PubMed Web of Science ®Google Scholar
• Mrsíc M, Horowitz MM, Atkinson K, et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant. 1992;9:269–275.
   PubMed Web of Science ®Google Scholar
• Radich JP, Sanders JE, Buckner CD, et al. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. J Clin Oncol. 1993;11:304–313.
   PubMed Web of Science ®Google Scholar
• Martino R, Badell I, Brunet S, et al. Second bone marrow transplantation for leukemia in untreated relapse. Bone Marrow Transplant. 1994;14:589–593.
   PubMed Web of Science ®Google Scholar
• Chiang KY, Weisdorf DJ, Davies SM, et al. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse. Bone Marrow Transplant. 1996;17:39–42.
   PubMed Web of Science ®Google Scholar
• Bosi A, Bacci S, Miniero R, et al. Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO). Leukemia. 1997;11:420–424.
   PubMed Web of Science ®Google Scholar
• Kishi K, Takahashi S, Gondo H, et al. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant. 1997;19:461–466.
   PubMed Web of Science ®Google Scholar
• Michallet M, Tanguy ML, Socié G, et al. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM). Br J Haematol. 2000;108:400–407.
   PubMed Web of Science ®Google Scholar
• Bosi A, Laszlo D, Labopin M, et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol. 2001;19:3675–3684.
   PubMed Web of Science ®Google Scholar
• Tomonari A, Iseki T, Ooi J, et al. Second allogeneic hematopoietic stem cell transplantation for leukemia relapse after first allogeneic transplantation: outcome of 16 patients in a single institution. Int J Hematol. 2002;75:318–323.
   PubMed Web of Science ®Google Scholar
• Eapen M, Giralt SA, Horowitz MM, et al. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant. 2004;34:721–727.
   PubMed Web of Science ®Google Scholar
• Al-Qurashi F, Ayas M, Al Sharif F, et al. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution. Hematology. 2004;9:123–129.
   PubMedGoogle Scholar
• Shaw BE, Mufti GJ, Mackinnon S, et al. Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplant. 2008;42:783–789.
   PubMed Web of Science ®Google Scholar
• Kedmi M, Resnick IB, Dray L, et al. A retrospective review of the outcome after second or subsequent allogeneic transplantation. Biol Blood Marrow Transplant. 2009;15:483–489.
   PubMed Web of Science ®Google Scholar
• Poon LM, Bassett R, Jr, Rondon G, et al. Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia. Bone Marrow Transplant. 2013;48:666–670.
   PubMed Web of Science ®Google Scholar
• Christopeit M, Kuss O, Finke J, et al. Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change. J Clin Oncol. 2013;31:3259–3271.
   PubMed Web of Science ®Google Scholar
• Tischer J, Engel N, Fritsch S, et al. Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation. Bone Marrow Transplant. 2014;49:895–901.
   PubMed Web of Science ®Google Scholar
• Vrhovac R, Labopin M, Ciceri F, et al. Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes. Bone Marrow Transplant. 2016;51:186–193.
   PubMed Web of Science ®Google Scholar
• Orti G, Sanz J, Bermudez A, et al. Outcome of second allogeneic hematopoietic cell transplantation after relapse of myeloid malignancies following allogeneic hematopoietic cell transplantation: a retrospective cohort on behalf of the Grupo Español de Trasplante Hematopoyetico. Biol Blood Marrow Transplant. 2016;22:584–588.
   PubMed Web of Science ®Google Scholar
• Ruutu T, de Wreede LC, van Biezen A, et al. Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. Bone Marrow Transplant. 2015;50:1542–1550.
   PubMed Web of Science ®Google Scholar
• Konuma T, Kato S, Ooi J, et al. Second allogeneic transplantation using unrelated cord blood for relapsed hematological malignancies after allogeneic transplantation. Leuk Lymphoma. 2016;57:103–109.
   PubMed Web of Science ®Google Scholar
• Byrd JC, Mrózek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002;100:4325–4336.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Ballen K, Rizzo D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628–1633.
   PubMed Web of Science ®Google Scholar
• Tachibana T, Tanaka M, Hagihara M, et al. Clinical significance of the administration of cytarabine or thiotepa in addition to total body irradiation and cyclophosphamide for allogeneic hematopoietic cell transplantation in patients with acute leukemia. Int J Hematol. 2015;102:451–459.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825–828.
   PubMed Web of Science ®Google Scholar
• Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204–217.
   PubMed Web of Science ®Google Scholar
• Tachibana T, Tanaka M, Numata A, et al. Pretransplant serum ferritin has a prognostic influence on allogeneic transplant regardless of disease risk. Leuk Lymphoma. 2012;53:456–461.
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48:452–458.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Hatsumi N, Takada S, et al. Haploidentical stem cell transplantation for acute leukemia patients who experienced early relapse within one year after the first transplantation. Transplant Proc. 2014;46:3611–3615.
   PubMed Web of Science ®Google Scholar
• Yeh SP, Lin CC, Lin CH, et al. Second haploidentical peripheral blood stem cell transplantation for treatment of acute leukemia with relapse after first allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2015;50:1001–1003.
   PubMed Web of Science ®Google Scholar